Brief: Aker Biomarine Signs First Commercial Agreement Signed For Lysoveta

Aker Biomarine ASA

01/09/2022 06:43

Sept 1 (Reuters) - Aker Biomarine ASA  AKBM.OL :
    * FIRST COMMERCIAL AGREEMENT SIGNED FOR LYSOVETA
    * LAUNCH OF FIRST MEDICAL FOOD AND DIETARY SUPPLEMENT IS
PLANNED
FOR 2024
    * UNDER AGREEMENT, AKER BIOMARINE WILL LICENSE, WITH
ASSOCIATED
ROYALTIES ON SALES, RELEVANT INTELLECTUAL PROPERTY RIGHTS AND
SUPPLY LYSOVETA TO TROFI
    * AKER BIOMARINE HAS SIGNED AN AGREEMENT WITH TROFI
NUTRITIONAL
INC. WITH AIM TO DEVELOP MEDICAL FOODS PRODUCTS BASED ON
LYSOVETA, TARGETING ALZHEIMER'S DISEASE, MALE INFERTILITY AND
GESTATIONAL DIABETES, IN ADDITION TO PRE-NATAL SUPPLEMENTS IN US
    * LAUNCH OF FIRST MEDICAL FOOD AND DIETARY SUPPLEMENT IS
PLANNED
FOR 2024

Source text for Eikon:  ID:nObiBjzkGa 
Further company coverage:  AKBM.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))